ENDRA Life Sciences Inc. (NASDAQ:NDRA) People

ENDRA Life Sciences Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Anthony DiGiandomenico
Other companies: Illumination Acquisition Corp I (Director · Since at least Feb 26, 2026); ClearSign Technologies Corporation (Director · Since at least May 22, 2025); eXoZymes Inc. (Board Member · Since at least Nov 8, 2024); MDB Capital Holdings, LLC (Co-Founder, Head of New Venture Discovery · Since at least Jul 25, 2023); Provention Bio Inc (Director · Jul 3, 2018 – May 15, 2020 · Past); Cue Biopharma, Inc. (Director · Dec 18, 2017 – Jan 2, 2019 · Past); Charlie's Holdings, Inc. (Director · Aug 4, 2006 – Aug 27, 2012 · Past)
Director · Since at least May 8, 2017
David R. Wells
Other companies: Fusemachines Inc. (Chief Financial Officer · Since at least Sep 1, 2026); Functional Brands, Inc. (Chief Financial Officer, Director · Since at least May 18, 2026); HeartSciences Inc. (Board Member · Since at least Dec 28, 2022); Envoy Medical, Inc. (Chief Financial Officer · Sep 29, 2023 – Oct 15, 2023 · Past); Sionix Corporation (President, CFO, Director · Dec 16, 2009 – May 7, 2012 · Past)
Chief Financial Officer · May 8, 2017 – Apr 5, 2021 · Past
Alexander Tokman
Other companies: MicroVision, Inc. (President and CEO, Director · Apr 13, 2006 – Feb 8, 2017 · Past)
CEO & Director · Since at least May 8, 2017
Lou Basenese
Other companies: ClearSign Technologies Corporation (Director · Since at least May 22, 2025)
Director · Since at least Apr 9, 2020
Renaud Bertrand Maloberti
Other companies: Bionik Laboratories Corp. (Chief Commercial Officer · Jun 11, 2018 – Jun 11, 2018 · Past)
Chief Commercial Officer · May 28, 2019 – Mar 28, 2022 · Past
Lou BaseneseDirector · Since at least Nov 4, 2026
Michael HarshDirector · Since at least Jun 11, 2025
Richard JacrouxChief Financial Officer · Since at least Nov 22, 2024
Scott SoberHead of Operations · Since at least Nov 4, 2026
Ziad RouagHead of Clinical and Regulatory · Since at least Nov 4, 2026